IDENTIFY STOCKS FOR VALUE INVESTING
WHAT you get
PAIN WE RELIEVE
PAIN WE RELIEVE
You gain access to updated buy-or-sell valuations of listed stocks.
Our information is based on intrinsic company valuations that are found within the institutional investment industry.
We don’t just publish our investment insights, we share the full details behind our recommendations, including every technical aspect of our modeling.
Our co
You gain access to updated buy-or-sell valuations of listed stocks.
Our information is based on intrinsic company valuations that are found within the institutional investment industry.
We don’t just publish our investment insights, we share the full details behind our recommendations, including every technical aspect of our modeling.
Our coverage spans a wide array of industries and liquid markets, from dynamic, fast-growing companies to established leaders and turnaround opportunities.
Our reports are focused on companies with positive equity, a minimum market capitalization of EUR 100 million, annual sales above EUR 50 million, and a free float of at least 45%. Only stocks with strong market liquidity on major Western exchanges are selected, ensuring easy access for investors.
To gain the clarity you need to recognize whether a stock is undervalued or overvalued by the market, subscribe to our newsletter:
PAIN WE RELIEVE
PAIN WE RELIEVE
PAIN WE RELIEVE
Private investors can be overwhelmed by the abundance of stock recommendations.
With AI increasingly involved in the selection process, investors are right to question available results.
Media sources often focus on technical chart analysis, repeat industry opinions, or simply relay financial content.
Online platforms and apps serve up stock
Private investors can be overwhelmed by the abundance of stock recommendations.
With AI increasingly involved in the selection process, investors are right to question available results.
Media sources often focus on technical chart analysis, repeat industry opinions, or simply relay financial content.
Online platforms and apps serve up stock picks using financial ratios or multiples, yet few explain that these are pricing shortcuts, not true company valuations.
Comprehensive company valuations and “fairness opinions” from auditors, banks, or professional advisory firms often entail significant costs.
VIAVALENS offers insight into professional valuations for a fraction of the costs.
We determine the intrinsic value of a stock by using discounted cash flow (DCF) models. Our proven methodology and our parameters are fully transparent.
VIAVALENS is equipping investors to critically evaluate any recommendation.
From uncertainty to confident decisions, say Goodbye to Guesswork.
WHY we do it
PAIN WE RELIEVE
WHY we do it
We believe that professional equity research should be available to everyone.
Our mission is to share our expertise with private and institutional investors at a fair price.
As advocates of value investing, we aim to provide clarity in an age of information overload and artificial intelligence.
Value investing is a responsible, long-term str
We believe that professional equity research should be available to everyone.
Our mission is to share our expertise with private and institutional investors at a fair price.
As advocates of value investing, we aim to provide clarity in an age of information overload and artificial intelligence.
Value investing is a responsible, long-term strategy, and we recommend holding stocks for extended periods until the market corrects its mispricing.
We avoid speculation and offer downside protection for those who want to participate in the stock market responsibly.
We are driven by a commitment to transparency and aim to make a meaningful contribution to the broader investment community.
Our professional insights help individuals understand how institutional investors operate and make decisions in a world saturated with information and noise.
For us, this means following the VIAVALENS path.